Aldeyra Therapeutics

IPO

Medicines to Treat Immune-Mediated Diseases | Aldeyra Therapeutics, Inc.

Public · Lexington, United States · $10.1M raised

Employees
11–50
Business Model
B2B
Total Funding
$10.1M
Last Round
$5.0M Series BJan 2013
Rounds
2
Type
Public

About

Aldeyra Therapeutics is a biotechnology company developing innovative therapies for immune-mediated diseases, including rare retinal conditions.

Summary

Aldeyra Therapeutics is a Biotech company based in Lexington, United States. It has raised $10.1M in total across 2 rounds, most recently a $5.0M Series B round in Jan 2013. Investors include Johnson & Johnson Innovation.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOMay 2014
$12.0M

Sign up to see all 3 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aldeyra Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/aldeyra-therapeutics"><img src="https://indexed.vc/api/badge/company/aldeyra-therapeutics" alt="Aldeyra Therapeutics on Indexed.vc" width="260" height="76" /></a>